Sector

IP aspirations for the new year

2025 presents a fresh opportunity to address emerging challenges.

Myanmar’ IP Experts 2024

A decade ago, in 2015, Asia IP visited Yangon, the commercial centre of Myanmar, for the first time, in search of Myanmar’s long-promised (and longer-awaited) suite of intellectual property laws.

Cambodia’ IP Experts 2024

Cambodia has strengthened its intellectual property framework with a comprehensive Intellectual Property Rights Recordation System (IPRRS).

Laos’ IP Experts 2024

The government of Laos convened its first Ministerial Conference on Blockchain 4.0 Digital Transformation in Vientiane in May 2023, its first step in advancing the country’s digital transformation through digital technology.

India’s IP Experts 2024

November brought good news for the Indian IP community: the country has recorded the world’s fastest growth in patent applications – an impressive 15.7 percent in 2023 over 2022’s rates – and has secured sixth position in the global Top 10 for patent...

Updates to Singapore’s regulations relating to patent linkage

Amendments to Singapore’s Health Products (Therapeutic Products) Regulations (the TPR) came into force on August 1, 2024, relating to patent linkage.

Patenting in biotechnology: Protecting your groundbreaking inventions

Patents play a crucial role in protecting biotechnological innovations. Simran Kaur Khalsa breaks down the Patent Act, 1970 as it applies to the patentability of biotechnology.

2024 Asia IP Awards winners crowned in Manila

Fifty-nine firms from 21 Asia-Pacific jurisdictions took home trophies at the 15th annual Asia IP Awards, held November 17 at Blackbird restaurant in Manila.

2024 India’s Top IP Firms and Practices Revealed

Asia IP’s editorial team reveals India’s top IP firms, practices.

AIPPI 2024: Panel discussion explores the future of digital therapeutics

The patentability of live biological products

Using live biological products in lifestyle drugs and cosmetics introduces a distinct set of considerations.

Federal Circuit upholds Myrbetriq patent, hinders generic launches

The U.S. Court of Appeals for the Federal Circuit criticized the actions of a lower court for potentially overstepping its authority.

What is patent evergreening?

Evergreening allows new patents to prolong their exclusive market position and delay the entry of generic competitors, but critical questions emerge about the nature and impact of these practices.

Novartis v. Natco imparts clarity on examination and opposition process under Patents Act being para...

In a decision dated January 9, 2024, the Delhi High Court clarified that the examination and opposition process, though statutorily structured to proceed parallelly, are independent and separate.

What should we know about the names of drugs?

When it comes to naming drugs, there’s more to consider than simply coming up with a snappy trade name. Ling Zhao and Qin Li explain how to navigate the three types of commercial identification of pharmaceuticals: the generic name, the trade name and...